Paxlovid appears to reduce the risk of dying from COVID-19 by 79% in those over 65
The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients aged 65 and older, according to a new study published in The New England Journal of Medicine. The pill, which is a combination of the drugs nirmatrelvir and ritonavir, received FDA emergency use authorization in …
Paxlovid appears to reduce the risk of dying from COVID-19 by 79% in those over 65 Read More »
